Montis Biosciences

Foundation date

19/07/2019

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Montis Biosciences’ mission is to therapeutically exploit cellular interactions between perivascular macrophages and tumor vasculature to drive and sustain immune reactions against solid tumors.

Montis Biociences was established based on the foundational science from the laboratories of Prof. Peter Carmeliet and Massimiliano Mazzone (VIB-KU Leuven), and is backed by an international syndicate of investors.

Upcoming events

Latest news

  • Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies

    1 day ago

  • Indigo Diabetes announces first participant enrolled in the SHINE clinical trial

    Thursday September 29th 2022

  • FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome

    Tuesday September 27th 2022